Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2016-06-09 Regulatory Filings
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the entry into a material definitive agreement and an amendment to that agreement, including payment terms and share issuance. It does not contain financial statements or detailed financial performance data. The document length is 3334 characters, which is relatively short and consistent with an 8-K filing. This type of filing is best classified under Regulatory Filings (RNS) as it is a general regulatory announcement and does not fit into more specific categories like Annual Report, Earnings Release, or Capital/Financing Update. Therefore, the appropriate classification is RNS with high confidence.
2016-06-09 English
10-Q/A
Interim / Quarterly Report Q2 2016
2016-05-16 English
FORM 10-Q
Interim / Quarterly Report Q2 2016
2016-05-16 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details a change in the company's independent registered public accounting firm due to a merger of accounting firms. It includes statements about the resignation of the previous auditor and the engagement of the new auditor, along with disclosures about disagreements and consultations. The document does not contain financial statements or detailed audit results itself but serves as an announcement of the change in auditor. Given the nature of the content and the form type (8-K), this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like Audit Report or Annual Report. The document length is 4350 characters, which is relatively short and consistent with an announcement rather than a full report.
2016-05-10 English
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details an amendment to the Articles of Incorporation to effect a forward stock split and increase authorized shares. This is a corporate event related to capital structure changes. The document is short (2546 characters) and does not contain financial statements or detailed financial analysis. It is not an annual or quarterly report, nor is it a management discussion or earnings release. The key event is a capital change (stock split and authorized shares increase). According to the filing definitions, announcements about capital structure changes fall under Capital/Financing Update (CAP). Therefore, the correct classification is CAP with high confidence.
2016-03-28 English
S-8 POS
Transaction in Own Shares Classification · 100% confidence The document is an Amendment No. 1 to a Form S-8 Registration Statement filed with the SEC. Form S-8 is used for registering securities to be offered under employee benefit plans, such as stock option plans. The text includes details about the securities being registered, the plan under which they are offered, and references to prior filings. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to share issuance under an employee plan. The document is lengthy (15,000 characters) and contains detailed registration information, not just an announcement. Therefore, the appropriate classification is Transaction in Own Shares (POS), which covers share repurchase or issuance filings including registration statements for employee stock plans.
2016-03-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.